Drug class in one race
NMDA receptor drugs for Major Depressive Disorder
11 tracked NMDA receptor drugs in the Major Depressive Disorder race. The class explanation lives on the NMDA receptor page; the full indication pipeline across every mechanism is on the Major Depressive Disorder page.
1 approved / phase 48 Phase 22 Phase 1
Head-to-head evidence: ACP-211 vs ALA-3000 · ACP-211 vs AV-101 · ACP-211 vs BI 1569912 · ACP-211 vs Blixeprodil · ACP-211 vs CLE-100 · ACP-211 vs Esketamine